Published
US government health officials have approved the first new drug for Alzheimer's disease in nearly twenty years. Regulators say the drug, which will be known as Aduhelm, is the first treatment that targets the causes of the disease, rather than its symptoms. But the approval is controversial - with some experts saying there's not enough firm evidence of real benefits.
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
#Alzheimers #Biogen #FDA
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
#Alzheimers #Biogen #FDA
- Category
- Europe
- Tags
- FDA, Alzheimer's disease, Biogen
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:35
US government approves Alzheimer’s drug to slow cognitive decline
-
16:02
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
-
01:02
European panel votes against Biogen’s Alzheimer’s drug
-
04:42
US FDA approves 1st new Alzheimer’s drug in nearly 20 years
-
02:45
US approves controversial new Alzheimer’s drug
-
01:55
U.S. FDA approves experimental Alzheimer's drug
-
01:33
Breakthrough or risk? FDA approves Alzheimer's drug
-
01:12
First patient receives Biogen Alzheimer's drug
-
01:17
FDA narrows patient group for Biogen's Alzheimer's drug
-
06:00
Why the FDA approved a controversial Alzheimer's drug
-
12:34
An Alzheimer’s Drug That Doesn’t Treat Alzheimer’s?
-
00:48
Biogen Alzheimer's drug closer to approval
-
02:01
Biogen to ship Alzheimer's drug in two weeks
-
01:59
Biogen shares soar on landmark Alzheimer's data
-
04:50
FDA approves new drug to slow progression of Alzheimer's
-
02:07
UK Alzheimer's patient positive after Biogen trials
-
01:32
Biogen CEO to step down after Alzheimer's drug snags
-
06:45
US approves first new Alzheimer's drug in 20 years - BBC News
-
1:35:01
ABC News Prime: FDA approves Alzheimer's drug; Ukraine counteroffensive; "Joy Ride" cast on new film
-
06:10
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
-
01:51
BVTV: Biogen’s Alzheimer's drug might exceed Wall Street expectations
-
08:30
Biogen Probed Over Price Gouging Dangerous Alzheimer’s Drug
Loading...